FDA ad­vi­sors unan­i­mous­ly rec­om­mend ac­cel­er­at­ed ap­proval for Bio­gen's ALS drug

A pan­el of out­side ad­vi­sors to the FDA unan­i­mous­ly rec­om­mend­ed that the agency grant ac­cel­er­at­ed ap­proval to Bio­gen’s ALS drug tofersen de­spite the drug fail­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.